A clinical trial to study the effects of herbal drug, Uricare tablet in patients with Prostate Enlargement
Phase 2
Completed
- Conditions
- Health Condition 1: null- Patients suffering from the Benign prostatic hyperplacia
- Registration Number
- CTRI/2016/04/006824
- Lead Sponsor
- PETLAD MAHAL AROGYA MANDAL PHARMACY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Patients having symptoms like Difficulty starting urine stream, Weal flow of urine, Dribbling of urine, Dysuria, Feeling like bladder is not completely empty are included for the study.
Exclusion Criteria
Patients already having Hypertension, Suffering from auto immune disorder, Spastic or genetic disorder, and also on long term steroidal treatment, who is not willing to fill Informed consent form, are excluded from the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The predefined primary end points are rapid symptomatic relief from Prostate Enlargment, Hypertention, and Urolithiasis.Timepoint: in 6 weeks of time period
- Secondary Outcome Measures
Name Time Method The predefined secondary endpoints are short- and long-term safety, and overall compliance to the drug treatmentTimepoint: in entire study time and also on follow up visits